fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Tagrisso (osimertinib) recommended for approval in the EU by CHMP for patients with unresectable EGFR-mutated lung cancer – AstraZeneca

Written by | 25 Nov 2024

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on the results from the LAURA Phase III trial,… read more.

Immuno-oncology treatment pre-surgery safe and effective option for localized non-small cell lung cancer

Written by | 23 Sep 2022

New study data shows that the immuno-oncology drug, atezolizumab (pronounced  a” te zoe liz’ ue mab, marketed as Tecentriq) is a safe and effective treatment for stage IB-IIIB… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.